Clinical trials referral resource. Current clinical trials of BAY 43-9006, Part 1.
Wright
John J
JJ
National Cancer Institute, Bethesda, MD, USA.
Zerivitz
Ken
K
Gravell
Amy
A
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D001557:Benzenesulfonates / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000008:administration & dosage*; D000077157:Sorafenib
D020533:Angiogenesis Inhibitors; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib